In topical application, studies use concentrations of 0.01-1% in cream or serum formulations (Pickart et al., BioMed Res Int 2015For subcutaneous injection (research), doses vary depending on the experimental model
Watch the Investor Day Presentation To view or add a comment, sign in Beyond its well-documented role in recovery, BPC-157 is increasingly appearing in functional wellness protocols alongside GLP-1 therapy with practitioners reporting patient benefits in energy, inflammation, and gut health that support broader metabolic goals
TL;DR Peptides are short chains of amino acids being marketed for knee inflammation and post-surgical recovery, with mixed evidence behind the claims
An anti-inflammatory agent that reduces the production of inflammatory molecules called cytokines
BPC-157 wird als Forschungschemikalie vermarktet, ist aber in den meisten Lndern nicht als Arzneimittel zugelassen und kann von rzten nicht verschrieben werden